➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Colorcon
AstraZeneca
McKinsey
Dow

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

TESTOSTERONE PROPIONATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Testosterone Propionate patents expire, and when can generic versions of Testosterone Propionate launch?

Testosterone Propionate is a drug marketed by Bel Mar, Elkins Sinn, Lilly, and Watson Labs. and is included in eight NDAs.

The generic ingredient in TESTOSTERONE PROPIONATE is testosterone propionate. There are sixty-nine drug master file entries for this compound. Additional details are available on the testosterone propionate profile page.

Summary for TESTOSTERONE PROPIONATE
Drug patent expirations by year for TESTOSTERONE PROPIONATE

US Patents and Regulatory Information for TESTOSTERONE PROPIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bel Mar TESTOSTERONE PROPIONATE testosterone propionate INJECTABLE;INJECTION 080741-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs TESTOSTERONE PROPIONATE testosterone propionate INJECTABLE;INJECTION 085490-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Elkins Sinn TESTOSTERONE PROPIONATE testosterone propionate INJECTABLE;INJECTION 080276-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs TESTOSTERONE PROPIONATE testosterone propionate INJECTABLE;INJECTION 080188-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Bel Mar TESTOSTERONE PROPIONATE testosterone propionate INJECTABLE;INJECTION 080742-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Bel Mar TESTOSTERONE PROPIONATE testosterone propionate INJECTABLE;INJECTION 080743-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs TESTOSTERONE PROPIONATE testosterone propionate INJECTABLE;INJECTION 080188-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
McKinsey
Moodys
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.